| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/J.GASTRO.2008.04.003 |
| P698 | PubMed publication ID | 18555017 |
| P50 | author | Paul Bo-San Lai | Q43682730 |
| Raymond Wai-Ming Lung | Q98162621 | ||
| Ka Fai To | Q99551275 | ||
| Chung Chan | Q110194398 | ||
| Nathalie Wong | Q114442539 | ||
| P2093 | author name string | Priscilla T-Y Law | |
| Queenie W-L Wong | |||
| P2860 | cites work | Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues | Q34997758 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 257-269 | |
| P577 | publication date | 2008-04-11 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | |
| P478 | volume | 135 |
| Q38948688 | A MDM2-dependent positive-feedback loop is involved in inhibition of miR-375 and miR-106b induced by Helicobacter pylori lipopolysaccharide |
| Q37453234 | A genetic variant in the promoter region of miR-106b-25 cluster predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese |
| Q28393439 | A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish |
| Q41647903 | A micro-RNA expression signature for human NAFLD progression |
| Q34147202 | A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma |
| Q39600327 | A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma |
| Q92634988 | Aberrant Expressional Profiling of Known MicroRNAs in the Liver of Silver Carp (Hypophthalmichthys molitrix) Following Microcystin-LR Exposure Based on samllRNA Sequencing |
| Q33688508 | Aberrant regulation of FBW7 in cancer |
| Q90163704 | Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma |
| Q39575083 | Analysis of CYP3A4 genetic polymorphisms in Han Chinese |
| Q33755766 | Apoptotic death of cancer stem cells for cancer therapy |
| Q34909994 | Association of MicroRNA-223 expression with hepatic ischemia/reperfusion injury in mice |
| Q39394724 | Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells |
| Q35677900 | C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer |
| Q33988586 | Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development |
| Q36316601 | Cell-free Circulating miRNA Biomarkers in Cancer |
| Q38046107 | Cellular and molecular mechanisms of hepatocellular carcinoma: an update |
| Q34266434 | Cellular microRNAs and picornaviral infections |
| Q34486635 | Circulating RNA molecules as biomarkers in liver disease |
| Q34217300 | Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs |
| Q38756678 | Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target |
| Q35675384 | Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer |
| Q40178952 | Circulating microRNA as a marker for predicting liver disease progression in patients with chronic hepatitis B. |
| Q38488956 | Comparison of microRNA expression profiles in HCC-derived microvesicles and the parental cells and evaluation of their roles in HCC. |
| Q98159067 | Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma |
| Q39681139 | Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. |
| Q35197356 | DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. |
| Q33838155 | Decrease expression of microRNA-744 promotes cell proliferation by targeting c-Myc in human hepatocellular carcinoma |
| Q39200123 | Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma |
| Q54090322 | Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway. |
| Q38719441 | Development of MicroRNA Therapeutics for Hepatocellular Carcinoma |
| Q38334014 | Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma. |
| Q33986171 | Differences in the properties and mirna expression profiles between side populations from hepatic cancer cells and normal liver cells |
| Q54431730 | Down-regulation of Dicer in hepatocellular carcinoma. |
| Q34992155 | Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance |
| Q98771219 | Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets |
| Q47259217 | EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma |
| Q34168267 | ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer |
| Q41592780 | Effects of microRNA-126 on cell proliferation, apoptosis and tumor angiogenesis via the down-regulating ERK signaling pathway by targeting EGFL7 in hepatocellular carcinoma |
| Q28118779 | Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma |
| Q35042179 | Emerging role of microRNA in hepatocellular carcinoma (Review) |
| Q27490492 | Emerging role of microRNAs in liver diseases |
| Q37844619 | Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma |
| Q37225034 | Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy |
| Q36382605 | Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications |
| Q86589279 | Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer |
| Q37645086 | Exosomes: small vesicles with big roles in hepatocellular carcinoma |
| Q38007998 | Exploiting p70 S6 kinase as a target for ovarian cancer |
| Q54339320 | Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. |
| Q37659419 | Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker. |
| Q41987857 | Expression and significance of circulating microRNA-31 in lung cancer patients |
| Q47163897 | Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics |
| Q41211534 | Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma |
| Q28383729 | From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms |
| Q36336198 | Function and clinical potential of microRNAs in hepatocellular carcinoma. |
| Q39166823 | Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells. |
| Q36402751 | Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma |
| Q39181475 | Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma |
| Q34258075 | H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands |
| Q43271612 | Hedgehog signaling regulates proliferation of prostate cancer cells via stathmin1. |
| Q51098591 | Hepatic mitochondrial DNA/Toll-like receptor 9/MicroRNA-223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in mice. |
| Q34765478 | Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. |
| Q37481988 | Hepatitis C Virus and HIV Type 1 Co-Infection |
| Q36413124 | Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. |
| Q36044846 | Human MiR-544a Modulates SELK Expression in Hepatocarcinoma Cell Lines. |
| Q37747546 | IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis. |
| Q29248741 | Identification of miRNA-mRNA Modules in Colorectal Cancer Using Rough Hypercuboid Based Supervised Clustering |
| Q38497311 | Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. |
| Q37799873 | Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis |
| Q34548464 | Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro |
| Q38107461 | Inflammation and liver tumorigenesis |
| Q34456584 | Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. |
| Q64996870 | Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors. |
| Q34993023 | Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties |
| Q40149856 | Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9. |
| Q39376558 | MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma |
| Q40767105 | MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells |
| Q92715804 | MiR-223 inhibits the proliferation, invasion and EMT of nasopharyngeal carcinoma cells by targeting SSRP1 |
| Q39113728 | MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells |
| Q34071730 | MiR-223 suppresses cell proliferation by targeting IGF-1R. |
| Q35657534 | MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells |
| Q38927623 | MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer. |
| Q42557466 | MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1 |
| Q38178272 | MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas |
| Q37295059 | MicroRNA and cancer--focus on apoptosis |
| Q35202304 | MicroRNA and hepatitis C virus--challenges in investigation and translation: a review of the literature |
| Q35061526 | MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival |
| Q37120757 | MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice |
| Q37361575 | MicroRNA involvement in hepatocellular carcinoma |
| Q37067623 | MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes |
| Q89405421 | MicroRNA miR-223 as regulator of innate immunity |
| Q33748980 | MicroRNA profiles discriminate among colon cancer metastasis |
| Q39429036 | MicroRNA profiles in various hepatocellular carcinoma cell lines |
| Q37208449 | MicroRNA profiling and head and neck cancer |
| Q41233695 | MicroRNA roles in the NF- κB signaling pathway during viral infections |
| Q27488310 | MicroRNA signatures in liver diseases |
| Q34987861 | MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines |
| Q46540341 | MicroRNA-182 plays an onco-miRNA role in cervical cancer. |
| Q90576975 | MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinoma |
| Q92965397 | MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes |
| Q36845623 | MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells |
| Q49997188 | MicroRNA-223 Suppresses the Canonical NF-κB Pathway in Basal Keratinocytes to Dampen Neutrophilic Inflammation. |
| Q34407669 | MicroRNA-223 coordinates cholesterol homeostasis |
| Q39407479 | MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. |
| Q39351860 | MicroRNA-223 regulates FOXO1 expression and cell proliferation |
| Q24621432 | MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7 |
| Q33838718 | MicroRNA-223-3p Regulates Ovarian Cancer Cell Proliferation and Invasion by Targeting SOX11 Expression. |
| Q36725131 | MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). |
| Q51821489 | MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells. |
| Q49021962 | MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression |
| Q35378724 | MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. |
| Q37330550 | MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C. |
| Q34794616 | MicroRNA-gene expression network in murine liver during Schistosoma japonicum infection |
| Q39528390 | MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. |
| Q38018170 | MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacy |
| Q47664260 | MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer |
| Q33661037 | MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects |
| Q35715931 | MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine |
| Q47599294 | MicroRNAs in Cerebral Ischemia |
| Q38166570 | MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC). |
| Q37431350 | MicroRNAs in cholangiociliopathies |
| Q38209676 | MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target |
| Q55444653 | MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. |
| Q37289662 | MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia |
| Q33815996 | MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets |
| Q37380881 | MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation |
| Q27015778 | MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy |
| Q24618771 | MicroRNAs: control and loss of control in human physiology and disease |
| Q37339409 | MicroRNAs: key modulators of posttranscriptional gene expression. |
| Q34750470 | Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor |
| Q28750201 | Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs |
| Q37399274 | Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22 |
| Q34469322 | Modulation of the osteosarcoma expression phenotype by microRNAs |
| Q64080308 | Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review |
| Q37407115 | Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors |
| Q33756006 | Molecular biology of liver cancer stem cells |
| Q37858630 | Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection |
| Q37649575 | Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. |
| Q53228628 | Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. |
| Q37031728 | New insights on the role of epigenetic alterations in hepatocellular carcinoma |
| Q37706520 | Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling |
| Q98906767 | Novel miRNA signature for predicting the stage of hepatocellular carcinoma |
| Q34940971 | Novel therapeutic strategies for targeting liver cancer stem cells |
| Q39827518 | Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells |
| Q35653780 | Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma |
| Q36980908 | Peripheral blood methylation profiling of female Crohn's disease patients |
| Q53556224 | Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. |
| Q47365487 | Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics |
| Q64120207 | Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells |
| Q99593441 | Progressive control of Streptococcus agalactiae-induced innate inflammatory response is associated with time-course expression of microRNA-223 by neutrophils |
| Q39089977 | Regulation of cytochrome b5 expression by miR-223 in human liver: effects on cytochrome P450 activities. |
| Q36997713 | Regulation of viral oncogenesis by microRNAs |
| Q41785826 | Relevance of Rabbit VX2 Tumor Model for Studies on Human Hepatocellular Carcinoma: A MicroRNA-Based Study |
| Q37781319 | RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N' Rho move it |
| Q58695698 | Role of miR-223 in the pathophysiology of liver diseases |
| Q38289553 | Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells |
| Q38346740 | Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells |
| Q35452140 | SATB1 and 2 in colorectal cancer |
| Q35745107 | STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells |
| Q36294432 | Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma |
| Q36509109 | Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma |
| Q34103110 | Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection |
| Q35061623 | Serum/plasma microRNAs as biomarkers for HBV-related hepatocellular carcinoma in China |
| Q37630481 | Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases |
| Q34217592 | Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer |
| Q37942978 | Stathmin: a protein with many tasks. New biomarker and potential target in cancer |
| Q37857056 | Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches. |
| Q39634084 | Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells |
| Q27004655 | Systemic mirnas as potential biomarkers for malignancy |
| Q35127831 | Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma. |
| Q57001209 | The Emerging Role of MicroRNAs in Hepatocellular Carcinoma |
| Q26800055 | The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis |
| Q26749450 | The Therapeutic Targets of miRNA in Hepatic Cancer Stem Cells |
| Q33579675 | The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma |
| Q27002614 | The function of miRNA in hepatic cancer stem cell |
| Q27003050 | The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update |
| Q37642381 | The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review |
| Q53426845 | The potential role of microRNA-31 expression in early colorectal cancer. |
| Q89700410 | The role of MicroRNAs in human cancer |
| Q38213933 | The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. |
| Q37601781 | The role of microRNAs in endometriosis and associated reproductive conditions |
| Q38164571 | The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. |
| Q34543731 | The role of microRNAs in liver cancer progression. |
| Q37901391 | The roles of microRNAs in tumorigenesis and angiogenesis. |
| Q34152847 | Therapeutics Based on microRNA: A New Approach for Liver Cancer |
| Q50053730 | Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis. |
| Q47206649 | Transcriptional landscapes of Axolotl (Ambystoma mexicanum). |
| Q26995383 | Tumor suppressor microRNAs: a novel non-coding alliance against cancer |
| Q21134532 | Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia |
| Q35908666 | VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma |
| Q53386859 | Validation of the isolation and quantification of kidney enriched miRNAs for use as biomarkers. |
| Q42473635 | c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18. |
| Q49681001 | miR-124 inhibits progression of hepatocarcinoma by targeting KLF4 and promises a novel diagnostic marker |
| Q39059633 | miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2. |
| Q33625493 | miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells |
| Q24646374 | miR-221 overexpression contributes to liver tumorigenesis |
| Q36509113 | miR-223 Deficiency Protects against Fas-Induced Hepatocyte Apoptosis and Liver Injury through Targeting Insulin-Like Growth Factor 1 Receptor |
| Q36983803 | miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor |
| Q37641780 | miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1. |
| Q91151354 | miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells |
| Q34832407 | miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma |
| Q88257420 | miR-223-5p Suppresses Tumor Growth and Metastasis in Non-Small Cell Lung Cancer by Targeting E2F8 |
| Q38114927 | miR-223: infection, inflammation and cancer |
| Q34219872 | miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma |
| Q35970800 | miR-31 is distinctively overexpressed in primary male extramammary Paget's disease |
| Q39917967 | miR-31: a master regulator of metastasis? |
| Q36197244 | miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3'-UTR region of CyclinD1 |
| Q47660322 | miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression |
| Q48171440 | miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis |
| Q39310720 | miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. |
| Q38231531 | miRNA in hepatocellular carcinoma |
| Q37697194 | miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations |
| Q42713756 | miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma |
| Q50248848 | miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells. |
| Q37652976 | miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma |
| Q38291943 | microRNA expression is able to predict response to chemoradiotherapy in rectal cancer |
| Q36230642 | microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma. |
| Q55252304 | microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A. |
| Q38175875 | microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma |
| Q37246198 | microRNAs in liver disease: from diagnostics to therapeutics |
Search more.